VIDEO: Platelet-rich plasma injection shows benefits in severe cases of dry eye disease

ByJorge L. Alió, MD, PhD

ByMichela Cimberle

Fact checked byChristine Klimanskis, ELS

MILAN — At the ESCRS meeting, Jorge Alió, MD, PhD, speaks about two innovative uses of platelet-rich plasma in ocular conditions not responsive to other treatments.

Injected in the anterior chamber, platelet-rich plasma showed encouraging outcomes in the treatment of severe cases of chronic ocular hypotony in a study with 1 year of follow-up, and injected in the main lacrimal gland and fornix, it is showing benefits for the treatment of severe dry eye disease.

Published by:

Sources/Disclosures

Collapse

Source:

Alió J. Sub conjunctival & lacrimal gland injection with platelet rich plasma (E-PRP) in treating chronic unresponsive dry eye disease. Presented at: European Society of Cataract and Refractive Surgeons meeting; Sept. 16-20, 2022; Milan.

Disclosures: Alió reports no relevant financial disclosures.

European Society of Cataract and Refractive Surgeons Meeting

Read more

VIDEO: Platelet-rich plasma injection shows benefits in severe cases of dry eye disease

Related Content